PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
EGF 27,487 Target Target Protein Fimh 21 1 0.00 -0.98 0.05 0.60
Inflammation 252,734 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.55
Carcinoma 433,099 Disease Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.54
Parkinsons Disease 124 Disease Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.76
Parkinsonism 13,164 Disease Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.62
ERK1 18,374 Target Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.61
CAPG 85 Target Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.78
BDNF 11,163 Target Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.62
Seborrhea 430 Disease Disease Cradle Cap 21 1 0.01 -0.97 0.05 0.72
Dandruff 360 Disease Disease Cradle Cap 21 1 0.01 -0.97 0.05 0.72
Respiratory Tract Infections 9,721 Disease Disease Cradle Cap 21 1 0.00 -0.98 0.05 0.63
Hypoglycemia 20,698 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.61
Seizure 44,685 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.59
Hormone Replacement Therapy 11,020 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.62
Depression 220,092 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.56
Brain Injury 34,874 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.60
Ovarian Cancer 33,996 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.60
Infection 766,637 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.53
Stroke 146,992 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.56
Major Depressive Disorder 12,517 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.62
Hyperthyroidism 16,816 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.61
Drug Abuse 13,496 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.62
Hearing Loss 30,622 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.60
Depression 220,092 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Influenza 67,933 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.58
BNP 6,842 Target Target CAMK2B 21 1 0.00 -0.98 0.05 0.64
Cholesterol 182,390 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Collagen 138,882 Target Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
CD4 112,219 Target Target CAMK1D 21 1 0.00 -0.98 0.05 0.57
Carcinoma 433,099 Disease Target CAMK1D 21 1 0.00 -0.98 0.05 0.54
Stroke 146,992 Disease Target CAMK1D 21 1 0.00 -0.98 0.05 0.56
Arava (Leflunomide)- FDA 14 Drug Drug Amevive (Alefacept)- FDA 21 1 0.06 -0.94 0.07 0.84
Skin Disease 6,955 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.63
Diabetes 332,602 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.55
Cancer 1,053,491 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.53
Skin Cancer 11,561 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.62
Acitretin (Soriatane)- FDA 13 Drug Drug Amevive (Alefacept)- FDA 21 1 0.06 -0.94 0.08 0.84
CNTF 1,613 Target Target Alpha Platelet-Derived Growth Factor Receptor 21 1 0.01 -0.98 0.05 0.68
AXL 633 Target Target Alpha Platelet-Derived Growth Factor Receptor 21 1 0.01 -0.98 0.05 0.70
Arava (Leflunomide)- FDA 14 Drug Drug Alefacept (Amevive)- FDA 21 1 0.06 -0.94 0.07 0.84
Skin Disease 6,955 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.63
Diabetes 332,602 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.55
Cancer 1,053,491 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.53
Skin Cancer 11,561 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.62
Obesity 138,233 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.57
Carcinoma 433,099 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.54
Ovarian Cancer 33,996 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.60
Scars 12,872 Disease Drug Dracorhodin 20 1 0.00 -0.97 0.05 0.62
Psychiatric Disorder 6,440 Disease Target Cyclooxygenase-3 20 1 0.00 -0.97 0.05 0.64
Diabetes 332,602 Disease Target BRSK1 20 1 0.00 -0.97 0.05 0.55